• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION FLEXIMA PLUS BILIARY; CATHETER, BILIARY, DIAGNOSTIC

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION FLEXIMA PLUS BILIARY; CATHETER, BILIARY, DIAGNOSTIC Back to Search Results
Model Number M00523490
Device Problems Break (1069); Migration (4003)
Patient Problems Anemia (1706); Hemorrhage/Bleeding (1888)
Event Date 08/07/2023
Event Type  Injury  
Event Description
It was reported to boston scientific that a flexima plus biliary stent was used and implanted during an endoscopic biliary stent placement procedure in the common bile duct, performed on (b)(6), 2023.Post procedure, on (b)(6), 2023, the patient suddenly collapsed and had experienced symptoms of anemia.A gastroscopy procedure was performed, and it was found that the stent had migrated, and the flap was caught in the papillary area when the stent was separated.On (b)(6), 2023, bleeding was confirmed from the papilla, and an endoscopic retrograde cholangiopancreatography for stent removal procedure was performed to remove the stent.The flexima plus biliary stent was successfully removed, and a new 7fr flexima plus biliary stent was implanted into the patient.The patient's condition at the conclusion of the procedure was reported to be stable.
 
Manufacturer Narrative
Block e1: initial reported address 1 and city: (b)(6).Block h6: imdrf device code a0401 captures the reportable event of stent break.Imdrf device code a010402 captures the reportable event of stent migration.Imdrf impact code f23 captures the reportable event of unexpected medical intervention.
 
Manufacturer Narrative
Block b5 has been updated based on the additional information received on october 3, 2023, and october 11, 2023.Block d4, h4: the complainant was unable to provide the suspect device lot number; therefore, the lot expiration and device manufacture dates are unknown.Block e1: initial reported address 1 and city: (b)(6).Block h6: imdrf device code a010402 captures the reportable event of stent migration.Imdrf impact code f23 captures the reportable event of unexpected medical intervention.Imdrf impact code f2303 captures the additional stent implanted on the patient.Block h11: correction to the initial mdr in block h6 (impact codes).
 
Event Description
It was reported to boston scientific that a flexima plus biliary stent was used and implanted during an endoscopic biliary stent placement procedure in the common bile duct, performed on (b)(6) 2023.Post procedure, on (b)(6) 2023, the patient suddenly collapsed and had experienced symptoms of anemia.A gastroscopy procedure was performed, and it was found that the stent had migrated, and the flap was caught in the papillary area when the stent was separated.On (b)(6) 2023, bleeding was confirmed from the papilla, and an endoscopic retrograde cholangiopancreatography for stent removal procedure was performed to remove the stent.The flexima plus biliary stent was successfully removed, and a new 7fr flexima plus biliary stent was implanted into the patient.The patient's condition at the conclusion of the procedure was reported to be stable.Additional information received on october 3, 2023, and october 11, 2023.Received clarification that the stent was not broken and that the reported term of stent separated indicated stent migration.A gastroscopy confirmed that the stent had migrated inside the duodenum.Additionally, compression with ablation and plastic stent implantation were performed to treat the patient's bleeding.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
FLEXIMA PLUS BILIARY
Type of Device
CATHETER, BILIARY, DIAGNOSTIC
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
300 boston scientific way
marlborough MA 01752
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
780 brookside drive
spencer IN 47460
Manufacturer Contact
carole morley
300 boston scientific way
marlborough, MA 01752
5086834015
MDR Report Key17886358
MDR Text Key325091881
Report Number3005099803-2023-05250
Device Sequence Number1
Product Code FGE
Combination Product (y/n)N
Reporter Country CodeJA
PMA/PMN Number
K965147
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Other,Foreign,Health Professional,Company Representative
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 10/31/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberM00523490
Device Catalogue Number2349
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 09/11/2023
Initial Date FDA Received10/06/2023
Supplement Dates Manufacturer Received10/11/2023
Supplement Dates FDA Received10/31/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-